Results from CRUSADE: Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines

CRUSADE investigated the association between dosing levels of antithrombotic agents and bleeding, in-hospital mortality, and length of stay in patients with NSTE ACS.

Excess dosing was associated with higher risks of bleeding and mortality, longer hospital stays, and was more common in patients with other risks for bleeding complications.

CRUSADE: NSTE ACS dosing of antithrombotics—study overview

Download VBWG06-CRUSADE.ppt (6 slides - 0.1MB)

CRUSADE: NSTE ACS dosing of antithrombotics—study overview Major predictors of overdosing Results: Excess dosing by age Results: Antithrombotic therapy dose and major bleeding Recommended dosing of antithrombotic agentsClinical implications

Click link to journal article:


Related at vwbg.org

RITA 3: Benefit of early invasive strategy in moderate-risk unstable angina patients

Final results of RITA 3 (Randomized Intervention Trial of unstable Angina) confirm that an interventional strategy results in a statistically significant reduction in the combined outcome of death, nonfatal myocardial infarction (MI), or refractory angina.

ERICA: Efficacy of Ranolazine In Chronic Angina

View/Download individual slides (11 Slides)

Core Curriculum

Antiplatelet Interventions in ACS

View/Download individual slides (104 Slides)
More related